ARIAD PHARMACEUTICALS INC Insider Trading for March 2016

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ARIAD PHARMACEUTICALS INC for March 2016.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 30 2016ARIAARIAD PHARMACEUTIC ...DesRosier ThomasEVP, General Counse ...Option ExerciseM0.0055,000055,000
Mar 30 2016ARIAARIAD PHARMACEUTIC ...DesRosier ThomasEVP, General Counse ...Payment of ExerciseF5.0318,37092,40136,63055 K to 36.6 K (-33.40 %)
Mar 30 2016ARIAARIAD PHARMACEUTIC ...DesRosier ThomasEVP, General Counse ...BuyM0.0055,000055,0000 to 55 K
Mar 23 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOSellS6.5823,834156,871316,212340 K to 316.2 K (-7.01 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOOption ExerciseM0.008,00000
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOSellS6.474,00025,86793,03997 K to 93 K (-4.12 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOBuyM0.008,000097,03989 K to 97 K (+8.98 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...Option ExerciseM0.004,75000
Mar 22 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...SellS6.472,37515,356262,115264.5 K to 262.1 K (-0.90 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...BuyM0.004,7500264,490259.7 K to 264.5 K (+1.83 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseM0.008,00000
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...SellS6.474,00025,871155,088159.1 K to 155.1 K (-2.51 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...BuyM0.008,0000159,088151.1 K to 159.1 K (+5.29 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...Option ExerciseM0.006,50000
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...SellS6.463,57523,102135,667139.2 K to 135.7 K (-2.57 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...BuyM0.006,5000139,242132.7 K to 139.2 K (+4.90 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOOption ExerciseM0.0010,83300
Mar 22 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOSellS6.475,41735,039340,046345.5 K to 340 K (-1.57 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOBuyM0.0010,8330345,463334.6 K to 345.5 K (+3.24 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VPOption ExerciseM0.0010,83300
Mar 22 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VPSellS6.475,41735,037320,367325.8 K to 320.4 K (-1.66 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VPBuyM0.0010,8330325,784315 K to 325.8 K (+3.44 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...Option ExerciseM0.006,50000
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...SellS6.473,57523,116147,011150.6 K to 147 K (-2.37 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...BuyM0.006,5000150,586144.1 K to 150.6 K (+4.51 %)
Mar 22 2016ARIAARIAD PHARMACEUTIC ...Soni Manmeet SinghEVP, CFO & Treasure ...Option ExerciseA6.47550,0003,558,500550,000
Mar 18 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...Option ExerciseM0.007,50007,500
Mar 18 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...Option ExerciseA0.0015,000015,000
Mar 18 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...Payment of ExerciseF6.212,43815,1405,0627.5 K to 5.1 K (-32.51 %)
Mar 18 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...BuyM6.217,50046,5757,5000 to 7.5 K
Mar 17 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseM1.303,7504,8750
Mar 17 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...SellD6.1822,814141,009132,024154.8 K to 132 K (-14.73 %)
Mar 17 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...BuyM1.303,7504,875154,838151.1 K to 154.8 K (+2.48 %)
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...Option ExerciseA0.0015,300015,300
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...Option ExerciseA6.5151,000332,01051,000
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...Option ExerciseA0.0018,000018,000
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...Option ExerciseA6.5160,000390,60060,000
Mar 09 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOOption ExerciseA0.0026,180026,180
Mar 09 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOOption ExerciseA6.5187,125567,18487,125
Mar 09 2016ARIAARIAD PHARMACEUTIC ...DesRosier ThomasEVP, General Counse ...Option ExerciseA0.0030,800030,800
Mar 09 2016ARIAARIAD PHARMACEUTIC ...DesRosier ThomasEVP, General Counse ...Option ExerciseA6.51102,500667,275102,500
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOOption ExerciseA0.0026,180026,180
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOOption ExerciseA6.5187,125567,18487,125
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...Option ExerciseA0.0023,400023,400
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Cole Hugh MSVP, Chief Business ...Option ExerciseA6.5178,000507,78078,000
Mar 09 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOOption ExerciseA0.0026,180026,180
Mar 09 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOOption ExerciseA6.5187,125567,18487,125
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseA0.0018,000018,000
Mar 09 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseA6.5160,000390,60060,000
Mar 03 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOOption ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOOption ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOSellS6.129,62558,866314,951324.6 K to 315 K (-2.97 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...FITZGERALD EDWARD MExecutive VP, CFOBuyM0.0019,2500324,576305.3 K to 324.6 K (+6.30 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...Option ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...Option ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...SellS6.129,62558,887259,740269.4 K to 259.7 K (-3.57 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...BERSTEIN DAVID LSVP, Chief IP Couns ...BuyM0.0019,2500269,365250.1 K to 269.4 K (+7.70 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOOption ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOOption ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOSellS6.129,62558,86389,03998.7 K to 89 K (-9.76 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Duvall Martin JEVP, CCOBuyM0.0019,250098,66479.4 K to 98.7 K (+24.24 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...Option ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...Option ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...SellS6.129,62558,869132,742142.4 K to 132.7 K (-6.76 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Cantor Maria ESVP, Corporate Affa ...BuyM0.0019,2500142,367123.1 K to 142.4 K (+15.64 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOOption ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOOption ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOSellS6.129,62558,867334,630344.3 K to 334.6 K (-2.80 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOSellS6.0025,047150,282344,255369.3 K to 344.3 K (-6.78 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...CLACKSON TIMOTHY PPresident, R&D, CSOBuyM0.0019,2500369,302350.1 K to 369.3 K (+5.50 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...Option ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...SellS6.119,62558,852151,088160.7 K to 151.1 K (-5.99 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Bollag Daniel MSr. VP, Reg. Affair ...BuyM0.0019,2500160,713141.5 K to 160.7 K (+13.61 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...Option ExerciseA0.0038,500038,500
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...Option ExerciseM0.0019,250019,250
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...SellS6.1110,58864,733144,086154.7 K to 144.1 K (-6.85 %)
Mar 03 2016ARIAARIAD PHARMACEUTIC ...Haluska FrankSVP, Clinical R&D, ...BuyM0.0019,2500154,674135.4 K to 154.7 K (+14.21 %)

Contact us | Follow us on Twitter